| AP-1 | activator protein-1 |
| ASC | apoptosis-associated speck-like protein containing a caspase recruitment domain |
| Casp-1 | caspase-1 |
| CD40 | cluster of differentiation 40 |
| CNS | central nervous system |
| CX3CL1 | fractalkine |
| CX3CR1 | fractalkine receptor |
| DCFH | 2′,7′-dichlorodihydrofluorescin |
| DCFH-DA | 2′,7′-dichlorofluorescin diacetate |
| DMEM | Dulbecco’s modified Eagle medium |
| ERK 1/2 | extracellular signal–regulated kinases |
| FBS | fetal bovine serum |
| HBSS | Hank’s balanced salt solution |
| HPA | hypothalamus-pituitary-adrenal |
| IκB | inhibitor of κB kinases |
| IGF-1 | insulin-like growth factor |
| IL | interleukin |
| iNOS | inducible nitric oxide synthase |
| JNK | c-Jun N-terminal kinases |
| CCL2/MCP-1 | chemokine CC motif ligand 2/monocyte chemoattractant protein-1 |
| MD-2 | myeloid differentiation protein-2 |
| MHC II | major histocompatibility complex class II |
| MTT | tetrazolium salt 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide |
| NF-κB | nuclear factor kappa-light-chain-enhancer of activated B cells |
| NLRP3 | NOD-like receptor pyrin-containing 3 inflammasome |
| NO | nitric oxide |
| PBS | phosphate-buffered saline |
| PKCδ | protein kinase C δ type |
| RIPA | radioimmunoprecipitation assay |
| ROS | reactive oxygen species |
| SSRIs | selective serotonin uptake inhibitors |
| TBS | Tris-buffered saline |
| TCAs | tricyclic antidepressants |
| TGF-β | transforming growth factor β |
| TLR | Toll-like receptor |
| TNF-α | tumor necrosis factor α |